PUI
AZN icon

Purpose Unlimited Inc’s AstraZeneca AZN Stock Holding History

Purpose Unlimited Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98M Buy
15,503
+1,264
+9% +$238K 0.11% 83
2026
Q1 		$2.81M Sell
14,239
-22,506
-61% -$4.34M 0.12% 92
2025
Q4 		$6.76M Buy
+36,745
New +$6.44M 0.31% 60

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Purpose Unlimited Inc's AZN Position: Q2 2026 in Review

Purpose Unlimited Inc increased its AstraZeneca (AZN) stake by 8.9% in Q2 2026, buying an estimated $238K and bringing the position to 15,503 shares worth $2.98M. The position accounts for 0.11% of the portfolio, ranked #83.

Purpose Unlimited Inc first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.76M in Q4 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Purpose Unlimited Inc held 15,503 shares of AstraZeneca worth $2.98M as of Q2 2026.
  • Purpose Unlimited Inc bought 1,264 AstraZeneca shares in Q2 2026, an estimated $238K.
  • AstraZeneca made up 0.11% of Purpose Unlimited Inc's portfolio in Q2 2026, its #83 holding.
  • Purpose Unlimited Inc first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Purpose Unlimited Inc's AstraZeneca position peaked at $6.76M in Q4 2025.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Purpose Unlimited Inc's 13F filing for Q2 2026, filed 13 Aug 2026.